RC
WST icon

Rovin Capital’s West Pharmaceutical WST Stock Holding History

Rovin Capital’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$602K Buy
2,189
+47
+2% +$12.9K 0.16% 112
2025
Q3 		$562K Buy
2,142
+175
+9% +$42.5K 0.16% 107
2025
Q2 		$430K Buy
1,967
+213
+12% +$45.5K 0.13% 128
2025
Q1 		$393K Buy
+1,754
New +$483K 0.13% 130

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Rovin Capital's WST Position: Q4 2025 in Review

Rovin Capital increased its West Pharmaceutical (WST) stake by 2.2% in Q4 2025, buying an estimated $12.9K and bringing the position to 2,189 shares worth $602K. The position accounts for 0.16% of the portfolio, ranked #112.

Rovin Capital first reported a position in WST in Q1 2025 and has held it in 4 quarters since. 804 funds tracked by Wall St. Rank hold WST as of Q4 2025.

  • Rovin Capital held 2,189 shares of West Pharmaceutical worth $602K as of Q4 2025.
  • Rovin Capital bought 47 West Pharmaceutical shares in Q4 2025, an estimated $12.9K.
  • West Pharmaceutical made up 0.16% of Rovin Capital's portfolio in Q4 2025, its #112 holding.
  • Rovin Capital first reported a position in West Pharmaceutical in Q1 2025 and has held it in 4 quarters since.
  • 804 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2025.

Based on Rovin Capital's 13F filing for Q4 2025, filed 9 Feb 2026.